Shenzhen Hepalink Pharmaceutical does not currently pay a regular dividend.
| Fiscal Year | Dividends Paid | Payout Ratio | YoY Change |
|---|---|---|---|
| 2025 | $430.81M | 123.3% | +169.4% |
| 2024 | $159.90M | 24.7% | -62.5% |
| 2023 | $425.89M | — | +69.7% |
| 2022 | $251.01M | 34.5% | -39.1% |
| 2021 | $412.48M | 171.3% | -7.8% |
| 2020 | $447.48M | 43.7% | +30.6% |
| 2019 | $342.51M | 32.3% | +34.2% |
| 2018 | $255.14M | 41.4% | -42.6% |
| 2017 | $444.58M | 338.5% | -17.9% |
| 2016 | $541.44M | 136.4% | +85.3% |
| 2015 | $292.27M | 50.4% | +11.3% |
| 2014 | $262.57M | 77.6% | — |